Despite the identification of Aβ plaques and NFTs as biomarkers for Alzheimer's disease
(AD) pathology, therapeutic interventions remain elusive, with neither an absolute …

Aim: Alzheimer's disease (AD) has been identified as a progressive brain disorder
associated with memory dysfunction and the accumulation of β-amyloid plaques and …

Alzheimer's disease (AD) is the most prevalent, progressive and multifaceted
neurodegenerative disorder associated with cognition, memory and behavioural …

Alzheimer's disease (AD) is one of the progressive neurodegenerative disorders and the
most common cause of dementia in the elderly worldwide causing difficulties in the daily life …

Background & Objective: Over the last two decades, Alzheimer disease (AD) associated
research has accomplished an overwhelming momentum, as it is one of the major current …

Alzheimer's disease (AD) is the most common cause of dementia, typically showing
progressive neurodegeneration in aging brains. The key signatures of the AD progression …

Alzheimer's disease (AD) is a severe cognitive impairment considered to be the leading
cause of dementia worldwide. The pathophysiology includes extracellular accumulation of …

Alzheimer's disease (AD) is an aging-related neurodegenerative disease and accounts for
majority of human dementia. The hyper-phosphorylated tau-mediated intracellular …

Alzheimer's disease (AD) is a neurodegenerative disease associated with the development
of dementia. It has been established that the pathological hallmarks of neurofibrillary tau …

Alzheimer's disease (AD) is one of the most prevailing neurodegenerative disorders of
elderly humans associated with cognitive damage. Biochemical, epigenetic, and …